Image credit Weight loss is an incredible journey; if you’ve been through it, you know how frustrating and overwhelmin ...

Brands like Kourtney Kardashian's Lemme are claiming to provide the same benefits as GLP-1 medications like Ozempic, Wegovy, ...

Tirzepatide, a dual GIP and GLP-1 receptor agonist, has gained widespread recognition for its effectiveness in promoting substantial weight loss by enhancing metabolic functions and controlling ...

Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filing in the gaps.

NBC 7 dives deep into the explosive popularity of the medications and explores both the life-changing benefits and the ...

The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in Eli ...

Many types of physicians are now prescribing GLP-1 receptor agonist medications for weight loss, but that doesn’t mean they are all suitable providers for a safe weight loss experience. A provider who ...

GLP-1 drugs such as Ozempic and Wegovy are providing new challenges for diet brands and gyms, who have seen a surge in demand ...

Novo Nordisk and Eli Lilly are currently dominating the weight loss drug market ... to account for roughly $70 billion of the total GLP-1 market, which is expected to be worth $200 billion ...

The EMA’s safety committee has said that, after a review of available data, it has found no evidence that GLP-1 agonist drugs such as Novo Nordisk’s Ozempic and Eli Lilly’s Trulicity can ...

The No. 4 Crimson Tide downed No. 1 Georgia 41-34 at Bryant-Denny Stadium ... a 75-yard score to Williams to take a lead the Crimson Tide wouldn't lose in the final three minutes of the win.